Step 1 topics → Renal → Cystic Kidney Diseases

Cystic Kidney Diseases

USMLE Step 1 trap: Attributes all ADPKD to PKD1 without recognizing the PKD2 variant and its milder phenotype. ADPKD is caused by mutations in PKD1 (chromosome 16, ~85% of cases, more severe) or PKD2 (chromosome 4, ~15%, milder course).

Cystic kidney diseases cover a spectrum from incidental benign findings to life-threatening inherited conditions, and USMLE Step 1 tests all of it. The high-yield core is ADPKD — genetics, extrarenal features, and clinical course — but the exam also distinguishes it from ARPKD, medullary entities, and simple cysts. Expect vignettes that give you age, family history, imaging findings, or an extrarenal clue (like a subarachnoid hemorrhage) and ask you to identify the disease or explain the mechanism.

The tricky part is that students treat these as isolated kidney diseases when most of them aren't. ADPKD causes berry aneurysms, mitral valve prolapse, and hepatic cysts. ARPKD causes congenital hepatic fibrosis — always. If a vignette describes a neonate with bilateral renal masses and liver disease, the liver involvement isn't incidental, it's diagnostic. Step 1 loves testing whether you know these extrarenal features because they're what distinguish these diseases from a generic 'cystic kidney' diagnosis.

The other major confusion point is the medullary diseases. Students lump medullary sponge kidney and medullary cystic disease together because both say 'medullary,' but they are almost opposite in clinical significance. One is a benign anatomical variant that predisposes to stones; the other is a progressive fibrotic disease that ends in ESRD. Getting that distinction right requires understanding pathophysiology, not just memorizing names.

From real student decks
81%have cards covering this topic
70%have mature cards

Common misconceptions

Common mistake
Wrong: ADPKD is caused by a single gene mutation (PKD1 only).
Right: ADPKD is caused by mutations in PKD1 (chromosome 16, ~85% of cases, more severe) or PKD2 (chromosome 4, ~15%, milder course).
PKD1 causes roughly 85% of ADPKD cases and produces a more severe phenotype — patients reach ESRD about a decade earlier than PKD2 patients. PKD2 (chromosome 4) accounts for the remaining ~15% and follows a milder course. The exam can test this by giving you a patient with a family history of ADPKD but late-onset renal failure, implying PKD2 rather than PKD1. Don't assume all ADPKD is PKD1.
Common mistake
Wrong: ARPKD only affects the kidneys.
Right: ARPKD is caused by PKHD1 mutations and invariably involves congenital hepatic fibrosis in addition to renal cysts.
ARPKD is caused by mutations in PKHD1 (chromosome 6), which encodes fibrocystin — a protein expressed in both renal tubular cells and hepatic bile duct epithelium. Because of this shared expression, congenital hepatic fibrosis is not a complication but a defining feature of ARPKD; it is present in essentially all cases. If a vignette shows an infant with enlarged echogenic kidneys and you see any mention of liver disease, ARPKD with hepatic fibrosis is the answer, not a separate diagnosis.
Common mistake
Wrong: Medullary sponge kidney and medullary cystic disease are the same entity.
Right: Medullary sponge kidney is a benign collecting duct ectasia predisposing to stones and infections, while medullary cystic disease (ADTKD) is a progressive fibrotic disease leading to ESRD.
The names overlap but the diseases don't. Medullary sponge kidney is a developmental collecting duct ectasia — the tubules dilate and predispose to nephrolithiasis and recurrent UTIs, but renal function is typically preserved and prognosis is benign. Medullary cystic disease, now classified as autosomal dominant tubulointerstitial kidney disease (ADTKD), involves progressive interstitial fibrosis with small, shrunken kidneys and inevitably progresses to ESRD. The distinction on Step 1 is: stones and infections point to medullary sponge kidney; progressive fibrosis and ESRD point to ADTKD.
Common mistake
Gap: Misses that ADPKD causes berry aneurysms and other extrarenal features beyond kidney enlargement
ADPKD has important extrarenal manifestations including berry aneurysms (subarachnoid hemorrhage risk), mitral valve prolapse, and hepatic/pancreatic cysts.
ADPKD is a systemic connective tissue disease, not just a kidney disease. The most high-yield extrarenal feature is intracranial berry aneurysms — patients have a significantly elevated risk of subarachnoid hemorrhage, and family history of SAH should prompt screening. Mitral valve prolapse and hepatic/pancreatic cysts round out the picture. On the exam, a vignette describing bilateral flank masses plus a young patient with sudden-onset severe headache (sentinel bleed or rupture) is essentially pointing at ADPKD even before you see the renal findings.
Free Deck audit

See if your Anki deck covers this topic.

Upload your deck →
Guided session

Stuck on this? An AI tutor that probes your understanding.

Start a session →

What the exam tests

  1. ADPKD genetics: distinguishing PKD1 (chromosome 16, ~85% of cases, more severe) from PKD2 (chromosome 4, ~15%, milder phenotype) and knowing this is autosomal dominant with adult-onset presentation.
  2. ADPKD extrarenal manifestations: berry aneurysms (subarachnoid hemorrhage risk), mitral valve prolapse, and hepatic and pancreatic cysts — and being able to identify these in a vignette as pointing toward ADPKD rather than another diagnosis.
  3. ARPKD genetics and features: PKHD1 mutation, autosomal recessive inheritance, infantile/neonatal presentation with bilateral renal cysts, and invariable congenital hepatic fibrosis.
  4. Simple vs complex renal cysts: imaging features that define a benign simple cyst (thin wall, anechoic, no septations) versus Bosniak criteria features that raise concern for malignancy.
  5. Medullary sponge kidney vs medullary cystic disease (ADTKD): distinguishing the benign collecting duct ectasia with stone/infection risk from the progressive autosomal dominant tubulointerstitial kidney disease that leads to ESRD.

Can you avoid these mistakes?

A 35-year-old man presents with bilateral flank pain and hematuria. Imaging shows massively enlarged kidneys with innumerable cysts. His father had dialysis-dependent kidney failure at age 58, and his paternal uncle died of a subarachnoid hemorrhage at age 45. What mutation is most likely responsible, and what chromosome is it on?
A newborn is found to have bilateral enlarged echogenic kidneys on ultrasound and is in respiratory distress from pulmonary hypoplasia. The mother reports the baby's older sibling also had kidney disease and died in infancy. What gene is mutated, and what finding would you expect on liver biopsy?
A 40-year-old woman with recurrent kidney stones and multiple UTIs undergoes CT imaging showing dilated collecting ducts in the medullary pyramids with small calcifications. Her serum creatinine is normal. What is the diagnosis, and how does it differ from medullary cystic disease in terms of prognosis?
An incidental 3 cm renal cyst is found on CT in a 55-year-old woman. It has a hairline-thin wall, is homogeneously anechoic with no internal septations, and shows no enhancement with contrast. What is the Bosniak classification, and does this require further workup or resection?

Related topics

Kidney Development (Pro-/Meso-/Metanephros) Congenital Renal Anomalies Nephron Structure and Segments Renal Vasculature (Afferent / Efferent / Vasa Recta)

See how your Anki deck covers this topic.

Upload your deck for a free audit →